Casillas, enigmatic: “A very special day in my life is coming”

first_imgIn fact, exercising as president of the Federation is incompatible with being a professional soccer player. To do this, he must first win the elections, although he is expected to announce his decision before that. Meanwhile, next June his contract with Porto expires, so if he wants to continue, he would need to reach an agreement with his current club. In four days, the date that Casillas uses as a reference, it is a year since he suffered a heart attack that has since distanced him from the playing fields. Back then, doctors gave him a year to make the final decision for his sports career. Beyond that, the goalkeeper has already dropped on occasion that the withdrawal from the world of football as he had lived until that fateful day was about to fall. The enigmatic message from Iker Casillas. Iker Casillas has published an enigmatic tweet, which has been deleted just a few minutes later. The candidate for the elections of the Royal Spanish Football Federation wrote the following: “Week important to me personally, a very special day in my life is coming. Many memories are crowded in my head, the first one, that September 12, 1999 when I made my debut as goalkeeper of the Real Madrid first team. Four days … # 1Year ago. “last_img read more

Read More →

Not unexpectedly a new drugresistant superbug pops up in the United States

first_imgOther research has focused on designing new antibiotics that bacterial evolution hasn’t yet anticipated. Last week, chemists at Harvard University described a powerful way to make new variations on the widely used class of antibiotics known as macrolides—a finding that spurred a new company. Meanwhile, governments are trying to find ways to incentivize the costly development of antibiotics—but as a Science feature detailed last year, an unfriendly market makes it hard to persuade companies that the search can be profitable. A new report from U.K. economist Jim O’Neill, also released last week, proposes a list of solutions to the resistance crisis, from new meat labeling practices to $1 billion incentives for drug companies. For years, public health experts have warned us that deadly bacteria are developing resistance to all our available antibiotics. This week, researchers reported the first known U.S. case of an Escherichia coli infection resistant to colistin, a harsh drug seen as a last resort to knock out stubborn infections. The finding, described in the American Society for Microbiology journal Antimicrobial Agents and Chemotherapy, is no big surprise to researchers tracking the rise of resistant bacteria. The resistance gene, known as mcr-1, was discovered in E. coli in China last year, and has since cropped up in Europe.As the United States crosses the same ominous milestone, research to understand resistance and develop new drugs is surging ahead. As Science reported earlier this month, evolutionary biologists have recently revisited old dogma about how best to prescribe antibiotics—revealing that trusted strategies such as using a high dose may not actually help prevent resistance.last_img read more

Read More →